German intestinal cancer care receives funding boost
This article was originally published in Clinica
A project initiated in 1999 by German Cancer Aid aimed at the detection and treatment of inherited intestinal cancer has met with overwhelming success, says the association, and is now entering its second phase. So far 852 families have registered with the project run by the association in co-operation with six university centres including Bochum, Bonn, Dresden, Dusseldorf, Heidelberg and Munchen/Regensburg. German Cancer Aid is to sponsor the second phase of the project to the tune of E5m ($5m).
You may also be interested in...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.
CMS acknowledges stakeholders may need more details about the plan before it is finalized and a delay will give the agency more time to ‘consider the issue.’
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.